Table 1.
Reference | Indication | Type of study |
---|---|---|
Chandley et al. (3) | MDD | Genetic |
Houston et al. (45) | Genetic | |
Egami et al. (47) | Biomarker | |
Nyberg et al. (55) | PET study | |
Rivero et al. (48) | Receptor density | |
Kuffel et al. (40) | Clinical trial | |
Nagao et al. (41) | Clinical trial | |
Cheng et al. (49) | SCZ | Genetic |
De Luca et al. (51) | Genetic | |
Liu et al. (50) | Genetic | |
Lochman et al. (53) | Genetic | |
Evers et al. (52) | Biomarker | |
Oranje and Glenthoj (39) | Clinical trial | |
Oranje and Glenthoj (42) | Clinical trial | |
Stenberg et al. (44) | Clinical trial | |
Terevnikov et al. (43) | Clinical trial |
MDD, major depressive disorder; SCZ, schizophrenia.